title: [Experience with amysil treatment of patients with vascular parkinsonism].
abstract: The results of treatment of 45 patients with vascular parkinsonism are reported. To the majority of the patients, daily amysil administration (1-2 mg 2-4 times a day) was prescribed. Most pronounced was the drug effect in patients with combined syndromes in which predominated bradikynesia (79.3%), rigidity (75%), and to a lesser extent, tremor (66.6%). In some patients, the sedative effect was evident. In most of the patients, the positive EMG changes were noticeable, especially in those with stage I of the disease.
authors.forename: V K
authors.initials: VK
authors.lastname: Kamenetskiĭ
mesh_terms: D000328:Adult; D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D001535:Benactyzine / Q000627:therapeutic use*; D002561:Cerebrovascular Disorders / Q000150:complications*; D002986:Clinical Trials as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy* / Q000209:etiology
chemical_list: D000978:Antiparkinson Agents; D001535:Benactyzine
vernacular_title: Opyt lecheniia amizilom bo'lnykh sosudistym parkinsonizmom.